Paliperidone Extended-Release Tablets and Parathyroid hormone Subcutaneous
Determining the interaction of Paliperidone Extended-Release Tablets and Parathyroid hormone Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: paliperidone
Brand name: Invega, Invega Sustenna, Invega Trinza
Synonyms: Paliperidone
Generic Name: parathyroid hormone
Brand name: Natpara
Synonyms: Parathyroid hormone, Parathyroid Hormone
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Paliperidone Extended-Release Tablets-Parcopa
- Paliperidone Extended-Release Tablets-Paregoric
- Paliperidone Extended-Release Tablets-Paremyd
- Paliperidone Extended-Release Tablets-Paremyd Ophthalmic
- Paliperidone Extended-Release Tablets-Paricalcitol
- Paliperidone Extended-Release Tablets-Paricalcitol Capsules
- Parathyroid hormone Subcutaneous-Paliperidone injection
- Parathyroid hormone Subcutaneous-Paliperidone Intramuscular
- Parathyroid hormone Subcutaneous-Palladone
- Parathyroid hormone Subcutaneous-Palmitate-A
- Parathyroid hormone Subcutaneous-Palonosetron
- Parathyroid hormone Subcutaneous-Palonosetron Hydrochloride